HCPCS Level IIdrugActive
J3401
Vyjuvek 5x10^9pfu/ml, 0.1 ml
BETOS: O1E
Effective: 2024-01-01
Referenced in 1 policies
Description
Beremagene geperpavec-svdt for topical administration, containing nominal 5 x 10^9 pfu/ml vector genomes, per 0.1 ml
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Vyjuvek
Manufacturer
Krystal Biotech, Inc.
HCPCS Dosage
0.1 ML
Billing Units
25.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.